Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context

摘要

Objectives. To examine whether We share or pharmaceutical industry Funds allocated to patient advocacy organizations (PAOs) is disproportionately large in the United States relative to other industrialized countries and to compare pharmaceutical companies' disclosure practices across industrialized countries.